MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

CNC · NYSE

Centene Corporation

Health Care · Medical Specialities

Reference price$60.68As of Jul 30, 2026
Market capitalization$29.98B
52-week range$25.08–$69.36
S&P 500 portfolio weight0.05%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$60.00-1.1% vs. reference
Average$70.93+16.9% vs. reference
High$80.00+31.8% vs. reference
6 Buy9 Hold0 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportNot availableSep 2026
Consensus EPS$0.176 estimates
Expected range-$0.01–$0.70Low to high EPS
Dec 2026$4.95Street EPS consensus
Dec 2027$4.83Street EPS consensus
Dec 2028$6.30Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue+19.4% YoY$195B$163B
Operating income($7.62B)$3.18B
Net income($6.67B)$3.31B
Operating cash flow$5.09B$0.15B
Capital expenditures($0.77B)($0.64B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

Zacks

UnitedHealth's Cost-Control Story is Gaining Momentum: Time to Buy?

Zacks

Centene Stock Q2 Earnings Call Highlights Margin Recovery

The Motley Fool

Centene (CNC) Q2 2026 Earnings Call Transcript

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.